In Brief: Cosmetics Bill Gains Co-Sponsors, Opponents; Unilever, Revlon Acquisitions; More
This article was originally published in The Rose Sheet
Executive Summary
Two more democratic senators sign on as co-sponsors of the Personal Care Products Safety Act; Cruelty Free calls the bill a “step in the right direction,” while the Handmade Cosmetic Alliance opposes the legislation, saying it would “jeopardize more than 300,000” small companies. More news in brief.
You may also be interested in...
Sen. Feinstein’s Cosmetics Safety Bill Launches With GOP Cosponsor
The Personal Care Products Safety Act would preempt duplicative state-level requirements for ingredient use and manufacturer responsibilities, addressing what has become one of the foremost banes of industry in recent years, while increasing FDA’s authority over the sector and giving it new responsibilities with regard to ingredient safety review. Additional compliance requirements for industry could prove challenging, but the positive PR likely to result from the legislation could help soften the blow.
In Brief: FDA, EPA Sharing Data; Industry Lead-In-Cosmetics Petition Goes Unanswered; More
FDA could use data collected under the Toxic Substances Control Act to inform its risk-assessment work, a March 16 update indicates, announcing a memorandum of understanding between FDA and the Environmental Protection Agency. More news in brief.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.